Critical care

Aimee Y. Yu, MD, Honored Posthumously with All Star Healthcare Solutions' All Star Cares Award

Retrieved on: 
måndag, augusti 9, 2021
Critical care, Star, National Association, CEO, MD, Heart, Multimedia, Friends, All-star, Patient, Hospital, Physician, Executive Committee, Medicine, Pharmaceutical industry

DEERFIELD BEACH, Fla., Aug. 9, 2021 /PRNewswire/ --All Star Healthcare Solutions has honored Aimee Y. Yu, MD, posthumously with its 2021 All Star Cares Award.

Key Points: 
  • DEERFIELD BEACH, Fla., Aug. 9, 2021 /PRNewswire/ --All Star Healthcare Solutions has honored Aimee Y. Yu, MD, posthumously with its 2021 All Star Cares Award.
  • Each year, All Star recognizes an extraordinary clinician in conjunction with National Locum Tenens Week.
  • The recipient of the prestigious All Star Cares Award is determined by Executive Committee based on nominations submitted by the company's people, clinicians, and/or clients.
  • All Star Healthcare Solutions is one of the fastest-growing healthcare staffing companies in the country.

Eagle Pharmaceuticals Announces Licensing Agreement with AOP Orphan for U.S. Commercial Rights to Landiolol, a Beta-1 Adrenergic Blocker

Retrieved on: 
måndag, augusti 9, 2021
Biotechnology, FDA, Health, Pharmaceutical, Clinical Trials, Compliance, Critical care, Review, NDA, Arrhythmia, Drug development, Growth, Solution, Forward-looking statement, Heart rate, AOP, U.S. Securities and Exchange Commission, Septic shock, Program, Meta-analysis, Private Securities Litigation Reform Act, Jean-Louis Vincent, COVID-19, Failure, Supraventricular tachycardia, PMID, Food, Adrenaline, Security (finance), Medication, Tariff, MD, Phrase, Shock, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Muscle, Atrial fibrillation, Patient, SEC, Â, Company, Population, FDA, Type, Blood pressure, Nasdaq, CNS, Sayyid, Heart, Eagle, Atrial flutter, Research, Heart failure, Pharmaceutical industry

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced that it has entered into a licensing agreement with AOP Orphan Pharmaceuticals GmbH (AOP Orphan), a privately owned Austrian company devoted to the treatment of rare and special diseases, for the commercial rights to its product, Landiolol in the United States.

Key Points: 
  • Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (Eagle or the Company) today announced that it has entered into a licensing agreement with AOP Orphan Pharmaceuticals GmbH (AOP Orphan), a privately owned Austrian company devoted to the treatment of rare and special diseases, for the commercial rights to its product, Landiolol in the United States.
  • Landiolol is a short-acting, ultra-high selective beta-1 adrenoceptor blocker developed by AOP Orphan that has a selective effect on heart rate over cardiac contractility.
  • Under the terms of the agreement, Eagle will facilitate the U.S. regulatory pathway for the approval of Landiolol.
  • AOP Orphan Pharmaceuticals GmbH is an international pharmaceutical company with its registered office in Vienna and a focus on rare and special diseases.

SaiOx, Inc. Selected to Present at the 2021 Venture Madness Conference in Phoenix, Arizona

Retrieved on: 
söndag, augusti 8, 2021
Southwestern United States, Technology, Disease, Entrepreneurship, Helium, Respiratory disease, University, Division, Conference, Death, Anesthesiology, Degenerative disease, COPD, Critical care, Oxygen, Carbon, Pharmaceutical industry, Video game

It was invented by Dr. Sairam Parthasarathy, M.D., Chief, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and was patented in September 2020.

Key Points: 
  • It was invented by Dr. Sairam Parthasarathy, M.D., Chief, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and was patented in September 2020.
  • SaiOx is licensing the exclusive use of the technology from the University of Arizona.
  • The group hosts the annual Venture Madness conference as their signature event to highlight emerging ideas and provide a platform for investors to discover new opportunities.
  • This year, the Invest Southwest Selection Panel chose 25 presenters for the conference, including selecting SaiOx to present in the medical category.

Long Island Jewish Forest Hills Notifies Patients Who Were Potentially Impacted by a Former Employee’s Unauthorized Access of Electronic Medical Records

Retrieved on: 
fredag, augusti 6, 2021
General Health, Hospitals, Health, Human services, Office of Inspector General, U.S. Department of Health and Human Services, Lung, Social Security, Northwell Health, Accountability Act, Critical care, Roger Hawkins (drummer), Hip, U.S. Department of Commerce Office of Security, Patient, Privacy, Economy, Certification, Social, Health Insurance Portability and Accountability Act, Breast, Long Island Jewish Forest Hills, Baby Friendly Hospital Initiative, Risk, Island, Time, Address, Insurance, American Association, Health Information Technology for Economic and Clinical Health Act, Experian, Association, Health insurance

Long Island Jewish Forest Hills Hospital (LIJFH) today announced that it has notified patients who were potentially impacted by a former employees unauthorized access of electronic medical records.

Key Points: 
  • Long Island Jewish Forest Hills Hospital (LIJFH) today announced that it has notified patients who were potentially impacted by a former employees unauthorized access of electronic medical records.
  • After receiving this subpoena, LIJFH reviewed the matter and determined that a former employee who was referenced in the subpoena improperly accessed certain electronic medical records.
  • Finally, the Compliance Department conducts audits of medical record access to minimize the risk of such incidents occurring in the future.
  • LIJFH has notified impacted patients and will notify relevant regulatory bodies, including the U.S. Department of Health and Human Services.

Longo’s Family Charitable Foundation commits $150,000 to area hospitals hardest hit by COVID-19

Retrieved on: 
onsdag, augusti 4, 2021
Longos, Trillium Health Partners, William Osler, Osler, Foundation, Charity, Ethics, Articles, Medicine

MISSISSAUGA, Ontario, Aug. 04, 2021 (GLOBE NEWSWIRE) -- In response to COVID-19 and in support of area hospitals hardest hit by the pandemic, the Longos Family Charitable Foundation has generously donated $150,000 toward Mackenzie Health, Trillium Health Partners (THP) and William Osler Health System (Osler).

Key Points: 
  • MISSISSAUGA, Ontario, Aug. 04, 2021 (GLOBE NEWSWIRE) -- In response to COVID-19 and in support of area hospitals hardest hit by the pandemic, the Longos Family Charitable Foundation has generously donated $150,000 toward Mackenzie Health, Trillium Health Partners (THP) and William Osler Health System (Osler).
  • A leader in philanthropy, the Longo family is committed to supporting health care in the communities where they operate.
  • To inspire community contributions, the Longos Family Charitable Foundation will match all offers received from donors up to $150,000.
  • We are incredibly proud to be supporting these three hospitals, says Rosanne Longo, Longos Spokesperson and Chair, Longos Family Charitable Foundation.

Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care

Retrieved on: 
onsdag, augusti 4, 2021
Branches of biology, Anatomy, Medical specialties, Blood, Hematology, Cardiovascular physiology, Blood volume, Transfusion medicine, Intravascular volume status, Blood test, Blood plasma, Capillary

Oak Ridge, TN, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data published in the journal Critical Care showing Daxor’s unique BVA-100 diagnostic blood test provides insights into the pathophysiology of volume derangements and capillary distress in critically ill COVID-19 patients enabling improved care.

Key Points: 
  • The Research Letter titled Blood volume and albumin transudation in critically-ill COVID-19 patients studied the abnormal blood volume profiles in mechanically ventilated patients admitted to the ICU at a leading medical center in New York.
  • The data shows that COVID-19 patients suffer from significant capillary damage and blood volume deficits that care teams became aware of through the use of the Daxor BVA-100 blood test.
  • Daxors BVA test is the first and only diagnostic test cleared by FDA that offers insights into patients blood volume with a 98% accurate measure of plasma and red cell volume.
  • We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms.

CipherHealth Unveils Next-Generation Patient Engagement Platform for Enhanced Personalization, Agility, and Scale to Improve Patient, Family, and Provider Experiences

Retrieved on: 
onsdag, augusti 4, 2021
Health, Medicine, Health care quality, Medical terminology, Patient, Health care

NEW YORK, Aug. 4, 2021 /PRNewswire/ -- CipherHealth , a recognized leader and innovator in patient-centered communications, engagement, and insights for the nation's leading healthcare systems, today announced the next generation of its Patient Engagement Platform.

Key Points: 
  • NEW YORK, Aug. 4, 2021 /PRNewswire/ -- CipherHealth , a recognized leader and innovator in patient-centered communications, engagement, and insights for the nation's leading healthcare systems, today announced the next generation of its Patient Engagement Platform.
  • "It's clear that yesterday's engagement strategies no longer meet the changing dynamics of the industry," said CipherHealth Chief Executive Officer Jake Pyles.
  • This allows patients to more efficiently and automatically manage their own appointment schedules, helping reduce care gaps while increasing patient satisfaction.
  • CipherHealth is an award-winning digital patient engagement company committed to enhancing communication and coordination throughout the care continuum.

Streamlining Brain Tumor Surgery Care During the Pandemic

Retrieved on: 
måndag, augusti 2, 2021
Medical specialties, Clinical medicine, Medicine, Neurosurgical procedures, Intensive care medicine, Intensive care unit, Craniotomy, Brain tumor

As U.S. health care eventually emerges from the pandemic, many aspects of surgical care, including how patients are prepared for surgery and where and how they recover will be forever altered.

Key Points: 
  • As U.S. health care eventually emerges from the pandemic, many aspects of surgical care, including how patients are prepared for surgery and where and how they recover will be forever altered.
  • The pandemic's strain on hospital ICUs and other facilities forced the PNI and Saint John's teams to reconsider some basic assumptions about brain tumor care and rapidly implement protocol enhancements that already had been in use on a more limited basis.
  • "Brain tumor surgery by craniotomy or endonasal removal is resource intensive and historically has required multi-day hospital admissions, often including recovery in the ICU," Dr. Kelly added.
  • There were no differences pre-pandemic versus pandemic in tumor removal rates, complications, readmissions or reoperations.

Fresenius Medical Care North America Announces New President for Renal Therapies Group

Retrieved on: 
torsdag, juli 22, 2021
Bad Homburg vor der Höhe, Private providers of NHS services, Fresenius, Societates Europaeae, Germany, Health care, Diaverum

WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.

Key Points: 
  • WALTHAM, Mass., July 22, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products, announced today that Joseph (Joe) Turk has been named President for the company's Renal Therapies Group.
  • Turk succeeds Mark Costanzo, who recently retired as President of FMCNA's Renal Therapies Group.
  • Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions.
  • Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent.

Rothman Index COVID-19 Research Receives STAR Research Award from the Society of Critical Care Medicine

Retrieved on: 
tisdag, februari 16, 2021
Data management, Health, Infectious diseases, Technology, Hospitals, Practice Management, Software, Society of Critical Care Medicine, SCCM, Critical care

PeraHealth is pleased to announce that Joseph Beals, PhD, Chief Analytics Officer, has been awarded a 2021 Star Research Achievement Award by the Society of Critical Care Medicine (SCCM).

Key Points: 
  • PeraHealth is pleased to announce that Joseph Beals, PhD, Chief Analytics Officer, has been awarded a 2021 Star Research Achievement Award by the Society of Critical Care Medicine (SCCM).
  • The SCCM Star Research Achievement Award is intended to recognize excellence in critical care research.
  • Recognition of this high-quality original investigative research with a Star Research Award underscores PeraHealths dedication to supporting its hospital partners during the COVID-19 pandemic.
  • Receiving a Star Research Award from the Society of Critical Care Medicine highlights the important efforts our hospital partners are making to help advance innovation and research even in the midst of the pandemic challenges.